NO852880L - Fremgangsmaate ved fremstilling av farmasoeytisk preparat med forsinket frigjoering - Google Patents

Fremgangsmaate ved fremstilling av farmasoeytisk preparat med forsinket frigjoering

Info

Publication number
NO852880L
NO852880L NO852880A NO852880A NO852880L NO 852880 L NO852880 L NO 852880L NO 852880 A NO852880 A NO 852880A NO 852880 A NO852880 A NO 852880A NO 852880 L NO852880 L NO 852880L
Authority
NO
Norway
Prior art keywords
particles
coating
ppa
resin
complex
Prior art date
Application number
NO852880A
Other languages
English (en)
Norwegian (no)
Inventor
Yegnaswami Raghunathan
Original Assignee
Pennwalt Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pennwalt Corp filed Critical Pennwalt Corp
Publication of NO852880L publication Critical patent/NO852880L/no

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/14Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/48Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005Wall or coating material
    • A61K9/5021Organic macromolecular compounds
    • A61K9/5036Polysaccharides, e.g. gums, alginate; Cyclodextrin
    • A61K9/5042Cellulose; Cellulose derivatives, e.g. phthalate or acetate succinate esters of hydroxypropyl methylcellulose
    • A61K9/5047Cellulose ethers containing no ester groups, e.g. hydroxypropyl methylcellulose
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/56Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule
    • A61K47/58Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. poly[meth]acrylate, polyacrylamide, polystyrene, polyvinylpyrrolidone, polyvinylalcohol or polystyrene sulfonic acid resin
    • A61K47/585Ion exchange resins, e.g. polystyrene sulfonic acid resin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/14Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605Excipients; Inactive ingredients
    • A61K9/1617Organic compounds, e.g. phospholipids, fats
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/14Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605Excipients; Inactive ingredients
    • A61K9/1629Organic macromolecular compounds
    • A61K9/1635Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates

Landscapes

  • Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
NO852880A 1984-07-18 1985-07-18 Fremgangsmaate ved fremstilling av farmasoeytisk preparat med forsinket frigjoering NO852880L (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US63197984A 1984-07-18 1984-07-18

Publications (1)

Publication Number Publication Date
NO852880L true NO852880L (no) 1986-01-20

Family

ID=24533574

Family Applications (1)

Application Number Title Priority Date Filing Date
NO852880A NO852880L (no) 1984-07-18 1985-07-18 Fremgangsmaate ved fremstilling av farmasoeytisk preparat med forsinket frigjoering

Country Status (11)

Country Link
EP (1) EP0171528A3 (da)
JP (1) JPH0649645B2 (da)
KR (1) KR920007568B1 (da)
AU (1) AU571659B2 (da)
CA (1) CA1236023A (da)
DK (1) DK324385A (da)
FI (1) FI852804A7 (da)
NO (1) NO852880L (da)
NZ (1) NZ211449A (da)
PH (1) PH20391A (da)
ZA (1) ZA853462B (da)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1987003197A1 (en) * 1985-11-29 1987-06-04 Fisons Plc Pharmaceutical composition including sodium cromoglycate
US4859462A (en) * 1986-07-30 1989-08-22 Fisons Corporation Polymer-treated ion exchange resins
NZ219925A (en) * 1986-07-30 1989-06-28 Pennwalt Corp Polymer-treated sulphonic acid cationic exchange resin particles
IE62100B1 (en) * 1986-07-30 1994-12-14 Fisons Corp Coated ion exchange resins
US4859461A (en) * 1986-07-30 1989-08-22 Fisons Corporation Coatable ion exchange resins
US4895723A (en) * 1986-09-08 1990-01-23 Amer And Company Cholestyramine compositions and method for preparation thereof
DE3719764A1 (de) * 1987-06-13 1988-12-22 Bayer Ag Ionenaustauscherharze beladen mit chinoloncarbonsaeurederivaten, ihre herstellung und verwendung
US4996047A (en) * 1988-11-02 1991-02-26 Richardson-Vicks, Inc. Sustained release drug-resin complexes
US5186930A (en) * 1988-11-14 1993-02-16 Schering Corporation Sustained release oral suspensions
US4999189A (en) * 1988-11-14 1991-03-12 Schering Corporation Sustained release oral suspensions
US5149523A (en) * 1989-06-20 1992-09-22 Aktiebolaget Hassle Polystyrenesulfonate-drug complex and solid dosage forms thereof
IT1241417B (it) 1990-03-06 1994-01-14 Vectorpharma Int Composizioni terapeutiche a rilascio controllato di farmaci supportatisu polimeri reticolati e rivestiti con film polimerici,e loro processodi preparazione
JP3286315B2 (ja) * 1990-06-20 2002-05-27 アドバンスト ポリマー システムズ,インコーポレイティド 可溶性活性物質の調節された放出のための組成物及び方法
HUT74642A (en) * 1990-12-21 1997-01-28 Richardson Vicks Inc Polyamine drug-resin complex
JP3278192B2 (ja) * 1992-04-03 2002-04-30 ロート製薬株式会社 徐放性液剤
US5350584A (en) * 1992-06-26 1994-09-27 Merck & Co., Inc. Spheronization process using charged resins
US20060083759A1 (en) * 2002-07-17 2006-04-20 Aleksander Resman Stabilization of the profile of release of active substances from a formulation
JP4808405B2 (ja) 2002-11-26 2011-11-02 ホ−レンベック ギャリ− ア−ル 高度に水溶性の電解質薬剤のための水性徐放性ドラッグデリバリーシステム
WO2006135362A1 (en) * 2005-06-09 2006-12-21 Upm Pharmaceuticals, Inc. Aqueous sustained-release drug delivery system for highly water-soluble electrolytic drugs
WO2010115015A1 (en) * 2009-04-03 2010-10-07 Coating Place, Inc. Modified-release pharmaceutical drug composition
ES2470940B1 (es) * 2012-12-21 2015-04-16 Laboratorios Rubió, S.A. Aducto entre un poliol y una resina de intercambio iónico
ES2471340B1 (es) 2012-12-21 2015-08-17 Laboratorios Rubió, S.A. Composición farmacéutica oral para fármacos de elevada posología

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2990332A (en) * 1958-04-02 1961-06-27 Wallace & Tiernan Inc Pharmaceutical preparations comprising cation exchange resin adsorption compounds and treatment therewith
DE2246037B2 (de) * 1972-09-20 1975-02-27 Taeschner & Co, 8831 Kipfenberg Peroral anwendbares Arzneimittel mit verzögerter Resorbierbarkeit in Suspensionsform
BE861141A (fr) * 1976-11-26 1978-03-16 Pennwalt Corp Preparations pharmaceutiques a liberation soutenue des substances actives
US4221778A (en) * 1979-01-08 1980-09-09 Pennwalt Corporation Prolonged release pharmaceutical preparations

Also Published As

Publication number Publication date
AU571659B2 (en) 1988-04-21
AU3963585A (en) 1986-01-23
JPS6130514A (ja) 1986-02-12
EP0171528A2 (en) 1986-02-19
EP0171528A3 (en) 1986-04-23
JPH0649645B2 (ja) 1994-06-29
FI852804L (fi) 1986-01-19
FI852804A7 (fi) 1986-01-19
FI852804A0 (fi) 1985-07-17
CA1236023A (en) 1988-05-03
KR920007568B1 (ko) 1992-09-07
DK324385D0 (da) 1985-07-17
PH20391A (en) 1986-12-10
KR860000865A (ko) 1986-02-20
NZ211449A (en) 1987-08-31
DK324385A (da) 1986-01-19
ZA853462B (en) 1985-12-24

Similar Documents

Publication Publication Date Title
NO852880L (no) Fremgangsmaate ved fremstilling av farmasoeytisk preparat med forsinket frigjoering
US4847077A (en) Controlled release pharmaceutical preparations
US4221778A (en) Prolonged release pharmaceutical preparations
Raghunathan et al. Sustained‐release drug delivery system I: Coated ion‐exchange resin system for phenylpropanolamine and other drugs
US5188841A (en) Sustained release pharmaceutical formulations
AU680891C (en) Controlled release preparation containing a salt of morphine
Anal et al. Chitosan–alginate multilayer beads for controlled release of ampicillin
US4859461A (en) Coatable ion exchange resins
CA1275048A (en) Drug particles having constant release and immediate release
Sutter et al. Parameters controlling drug release from pellets coated with aqueous ethyl cellulose dispersion
RS50924B (sr) Oralni dozni oblici propiverina ili njegovih farmaceutski prihvatljivih soli sa produženim oslobađanjem aktivne materije
SE455836B (sv) Beredning med kontrollerad frisettning innehallande ett salt av metoprolol samt metod for framstellning av denna beredning
JP2670777B2 (ja) 被覆性イオン交換樹脂
Ichikawa et al. Design of prolonged-release microcapsules containing diclofenac sodium for oral suspensions and their preparation by the Wurster process
US4859462A (en) Polymer-treated ion exchange resins
EP0212746A2 (en) Drug particles having constant release
FI65910C (fi) Foerfarande foer framstaellning av farmaceutiska preparat med laongtidsverkan
Lee et al. Preparation and characterization of melatonin-loaded stearyl alcohol microspheres
CA1283497C (en) Polymer-treated ion exchange resins
Mathir et al. In vitro characterization of a controlled-release chlorpheniramine maleate delivery system prepared by the air-suspension technique
Fundueanu et al. Cation exchange hydrogels as platform for loading and controlled delivery of drug
Sheen et al. Aquesons Films Coating Stuied of Sustabined Release Niciotine Acid Fellets: An In-Vitro Evalutiion
El-shattawy et al. Phenylpropanolamine HCL microcapsules: Preparation and release studies
Funaro This is Pharma Website
WO2000069411A1 (en) Use of polymeric adsorbents in pharmaceutical dosage forms